As an alternative to antihelminthic drugs, we are exploiting vaccination to control infections with the abomasal nematode Ostertagia ostertagi in cattle. Our focus for vaccine targets is excretory-secretory (ES) products of this parasite. One of the most abundant antigens in larval and adult Ostertagia ES products is a protein homologous to nematode polyprotein allergens. We found that the Ostertagia polyprotein allergen (OPA) is encoded by a single-copy gene. OPA comprises three or more repeated units, and only the 15-kDa subunits are found in ES products. The native antigen is localized in the intestinal cells of third-stage larvae and in the hypodermis and cuticle of fourth-stage larvae and adult parasites. Vaccination of cattle with native OPA (nOPA) in combination with QuilA resulted in protection against Ostertagia challenge infections. The geometric mean cumulative fecal egg counts in the nOPA-vaccinated animals were reduced by 60% compared to the counts in the control group during the 2-month course of the experiment. Both male and female adult worms in nOPA-vaccinated animals were significantly shorter than the worms in the control animals. In the abomasal mucus of vaccinated animals the nOPA-specific immunoglobulin G1 (IgG1) and IgG2 levels were significantly elevated compared to the levels in the control animals. Reductions in the Ostertagia egg output and the length of the adult parasites were significantly correlated with IgG1 levels. IgG2 titers were only negatively associated with adult worm length. Protected animals showed no accumulation of effector cells (mast cells, globular leukocytes, and eosinophils) in the mucosa. In contrast to the native antigen, recombinant OPA expressed in Escherichia coli did not stimulate any protection.At present, the control of Ostertagia ostertagi infections in cattle largely depends on the use of chemical antihelminthic drugs. Residues of introduced chemicals in foodstuffs and the environment have become a serious consumer concern. Reports of resistance to antiparasitic drugs for a closely related parasite, Cooperia species, in cattle (5, 31) make the development of alternative control systems even more urgent.Early attempts to protect cattle against the abomasal nematode O. ostertagi with irradiated larval vaccines (2) or with crude somatic (12) and excretory-secretory (ES) products (13) were not successful. Moderate levels of protection were obtained in calves immunized with gut membrane glycoproteins of O. ostertagi (24). Recently, it was shown that vaccination of cattle with ES products of adult Ostertagia worms enriched for cysteine proteinases by thiol-Sepharose chromatography reduced the fecal egg counts by 60% compared to the counts in the control group (11).Generally, ES products are considered to be essential for the development and survival of the parasite within the host and are targets for vaccine development (17). Immunoscreening of cDNA libraries of both larvae (third-stage larvae [L3] and L4)